1. An Induced Pluripotent Stem Cell‐Derived Neuromuscular Junction Platform for Study of the NGLY1‐Congenital Disorder of Deglycosylation. Issue 11 (19th August 2022) Authors: Sasserath, Trevor; Robertson, Ashley L.; Mendez, Roxana; Hays, Tristan T.; Smith, Ethan; Cooper, Helena; Akanda, Nesar; Rumsey, John W.; Guo, Xiufang; Farkhondeh, Atena; Pradhan, Manisha; Baumgaertel, Karsten; Might, Matthew; Rodems, Steven; Zheng, Wei; Hickman, James J. Journal: Advanced therapeutics Issue: Volume 5:Issue 11(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a Broadly Applicable Assay for Measurement of Glycan-Directed Enzymatic Activity. (October 2018) Authors: Bresciani, Alberto; Cecchetti, Ottavia; Missineo, Antonino; Pacifici, Pier Giorgio; Tomei, Licia; Rodems, Steven Journal: SLAS discovery Issue: Volume 23:Number 9(2018) Page Start: 941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Induced pluripotent stem cells for neural drug discovery. Issue 4 (April 2019) Authors: Farkhondeh, Atena; Li, Rong; Gorshkov, Kirill; Chen, Kevin G.; Might, Matthew; Rodems, Steven; Lo, Donald C.; Zheng, Wei Journal: Drug discovery today Issue: Volume 24:Issue 4(2019) Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗